IL10 and neoplasm: T cells cocultured with IL-10-stimulated cells of K1 and TPC-1 exhibited increased cell activation (%CD25+ of CD3+ T cells) and IL-2 production at an E:T ratio of 30:1, which was evidence for promotion in tumor immunity in PTC.